---
layout: minimal-medicine
title: Elapegademase
---

# Elapegademase
### Generic Name
Elapegademase

### Usage
Elapegademase is a prescription medicine used to treat adenosine deaminase-severe combined immunodeficiency (ADA-SCID) in patients. ADA-SCID is a rare, inherited disorder affecting the immune system's ability to fight off infections.  Elapegademase works by replacing the missing or deficient enzyme, adenosine deaminase, which is crucial for proper immune function.  This helps improve the immune system's ability to combat infections.

### Dosage

**Dosage for ADA-SCID:**  The dosage of elapegademase is complex and highly individualized, depending on factors like the patient's weight, previous treatment (if any with pegademase bovine), and response to therapy.  It is always administered intramuscularly (IM).  

* **Pegademase bovine-naive patients (adults and children):**  Initial doses typically range from 0.2 mg/kg to 0.4 mg/kg per week, often divided into two doses given twice weekly. The minimum duration of treatment is 12-24 weeks, after which the dosage is adjusted based on the patient's response.  Monitoring of trough ADA activity, deoxyadenosine nucleotide (dAXP) levels, and lymphocyte counts guides dose adjustment.

* **Patients transitioning from pegademase bovine:** The starting dose of elapegademase depends heavily on the previous pegademase bovine dosage.  A specific formula is used for dose calculation, and subsequent adjustments are made based on clinical response and laboratory values (ADA activity, dAXP levels, lymphocyte counts).

**Important Note:**  The information above provides a general overview.  The precise dosage regimen should be determined and closely monitored by a physician experienced in managing ADA-SCID.  Dosage adjustments are made frequently based on laboratory results and the patient’s clinical response.  No specific dosage adjustments are currently provided for hepatic or renal impairment.


### Side Effects

Common side effects may include:

* Injection site discomfort
* Fatigue
* Nausea
* Vomiting
* Diarrhea
* Headache
* Skin rash

Less common, but more serious side effects can include:

* Seizures
* Severe infections
* Hematologic abnormalities (e.g., neutropenia)
* Pulmonary problems

It is crucial to report any side effects to your doctor immediately.

### How it Works

Elapegademase is a recombinant form of the enzyme adenosine deaminase (ADA). In individuals with ADA-SCID, a deficiency or absence of ADA leads to the buildup of toxic levels of adenosine and deoxyadenosine. These substances are harmful to lymphocytes (immune cells), resulting in severe immunodeficiency. Elapegademase acts as a replacement ADA enzyme, breaking down these toxic metabolites.  This allows for the proper development and function of lymphocytes, thereby strengthening the immune system's ability to fight infection.

### Precautions

* **Pregnancy and breastfeeding:** The safety of elapegademase during pregnancy and breastfeeding is unknown.  Discuss the risks and benefits with your doctor.
* **Thrombocytopenia:**  Patients with low platelet counts (thrombocytopenia) have an increased risk of bleeding at the injection site.
* **Immunocompromised patients:** Elapegademase should be used cautiously in patients with compromised immune systems due to the potential for increased risk of infections.
* **Drug interactions:** Elapegademase may interact with other drugs.  Always inform your doctor of all medications you are taking. Pegloticase may decrease the effect of elapegademase, while elapegademase may increase the effects of pegvaliase.
* **Administration:** Elapegademase is for intramuscular injection only; it must not be administered intravenously or subcutaneously.  The medication should be administered immediately after preparation, avoiding arteries and nerves, and rotating injection sites.


### FAQs

* **Q: How is elapegademase stored?** A: Elapegademase should be refrigerated (2-8°C) in its original carton, protected from light.  Do not freeze or shake.

* **Q: How long does it take to see results?** A: The time it takes to see improvement varies from patient to patient. Regular monitoring of immune function is crucial for assessing the effectiveness of the treatment.

* **Q: Are there any long-term effects?** A: Long-term effects of elapegademase are not fully established.  Close monitoring is needed throughout the treatment.

* **Q: What should I do if I miss a dose?** A: Consult your doctor immediately to determine the appropriate course of action.

* **Q: Can elapegademase cure ADA-SCID?** A: Elapegademase is not a cure, but it can significantly improve immune function and quality of life for patients with ADA-SCID.

**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  This information is based on available data and may not be exhaustive.  Always refer to the official prescribing information for the most complete and up-to-date details.
